- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03760497
Three Restorative Protocols in MIH: a Randomized Controlled Clinical Study
Comparison of Three Restorative Protocols in Teeth With Molar-Incisor Hipomineralization (MIH): a Randomized Controlled Clinical Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
São Paulo
-
Ribeirão Preto, São Paulo, Brazil, 14040-904
- Recruiting
- School of Dentistry of Ribeirão Preto
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least one permanent first molar with occlusal surface with severe MIH grade (with post eruptive enamel fracture and dentin exposure), it may not be reported hypersensitivity in the selected tooth.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: CIV Group
Temporary Restoration with Glass Ionomer (Equia Forte® - GC Corporation, Tokyo, Japan) for 30 days + Restoration in Composite Resin (Filtek® Resin Z350 XT - 3M Corporate Headquarters, St. Paul, USA).
|
For all groups, first the patients will be submitted to the anesthetic technique indicated with Lidocaine + Epinephrine 1: 100,000 (New DFL, Rio de Janeiro, Brazil), followed by absolute isolation with rubber sheet and metal clamp; then prophylaxis of the selected tooth will be performed with Robson's brush and pumice stone and water, surface washing and drying with cotton balls, removal of carious tissue or affected enamel without dentin support with sharp curettes or low-speed spherical drills.
Subsequently, each group will follow the treatment protocols suggested by the manufacturer of restorative materials.
|
|
EXPERIMENTAL: Composite Resin Group
Restoration with Composite Resin (Filtek® Resin Z350 XT - 3M Corporate Headquarters, St. Paul, United States).
|
For all groups, first the patients will be submitted to the anesthetic technique indicated with Lidocaine + Epinephrine 1: 100,000 (New DFL, Rio de Janeiro, Brazil), followed by absolute isolation with rubber sheet and metal clamp; then prophylaxis of the selected tooth will be performed with Robson's brush and pumice stone and water, surface washing and drying with cotton balls, removal of carious tissue or affected enamel without dentin support with sharp curettes or low-speed spherical drills.
Subsequently, each group will follow the treatment protocols suggested by the manufacturer of restorative materials.
|
|
EXPERIMENTAL: Composite Resin Group + Laser
Composite Resin Restoration (Filtek® Resin Z350 XT - 3M Corporate Headquarters, St. Paul, USA) + Application of Diode Laser.
|
For all groups, first the patients will be submitted to the anesthetic technique indicated with Lidocaine + Epinephrine 1: 100,000 (New DFL, Rio de Janeiro, Brazil), followed by absolute isolation with rubber sheet and metal clamp; then prophylaxis of the selected tooth will be performed with Robson's brush and pumice stone and water, surface washing and drying with cotton balls, removal of carious tissue or affected enamel without dentin support with sharp curettes or low-speed spherical drills.
Subsequently, each group will follow the treatment protocols suggested by the manufacturer of restorative materials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Longevity of restorations
Time Frame: 24 months.
|
The main purpose will be the longevity of the desserts in elaborate compounds, according to the three protocols. Images should be analyzed and scanned. Radiographic examination and digital radiography. After 6, 12 and 24 months. |
24 months.
|
|
Treatment satisfaction as assessed by VAS scale (Index 0 to 10)
Time Frame: After 1 week of treatment, 1, 12 and 24 months.
|
After 1 week of treatment, 1, 12 and 24 months, the caregiver will be asked to respond about the satisfaction regarding the care (treatment and returns) received.
He should classify his satisfaction using the VAS scale with indexes from 0 to 10, with 0 being the worst treatment evaluation and 10 being the best.
|
After 1 week of treatment, 1, 12 and 24 months.
|
|
Discomfort referred by the children assessed by Wong-Baker Facial Scale (Very smiling to very sad)
Time Frame: On treatment day
|
In order to assess the discomfort reported by the children in relation to the type of treatment received, the same timekeeping operator will apply the Wong-Baker Facial Scale to the patient, which is composed of six figures with equidistant faces.
that the first one is very smiling and the expressions are changing, until the last one is very sad.
|
On treatment day
|
|
Quality of life assessed by Child Perceptions Questionnaire 8-10 (CPQ8-10) (Assessed by questions)
Time Frame: On treatment day
|
To assess the impact of MIH on children's quality of life, the Child Perceptions Questionnaire 8-10 (CPQ8-10), specially developed for children aged 8-10 years and validated in the Portuguese language.
This scale was assessed through questions and answers to a children's quality of life.
|
On treatment day
|
|
Anxiety Assessment
Time Frame: On treatment day
|
For the assessment of anxiety in the study children, the Children's Fear Survey Schedule-Dental Subscale will be used
|
On treatment day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Socioeconomic questionnaire
Time Frame: On treatment day
|
Information obtained through a socioeconomic questionnaire and questions related to the individual characteristics of the child, such as, for example, fluoride exposure variables, oral hygiene practices and eating habits.
|
On treatment day
|
|
Evaluation of the caries experience
Time Frame: On treatment day
|
Evaluation of the caries experience by the ceo-d / CPO-D indices
|
On treatment day
|
|
Presence of biofilm visible
Time Frame: On treatment day
|
Presence of biofilm visible through the Simplified Oral Hygiene Index in which six surfaces will be used to represent the entire mouth: the vestibular of the first right and left first molars, the lingual of the first right and left first molars, and the vestibular surface of the upper central incisor right and bottom left
|
On treatment day
|
|
Evaluation of the visible biofilm accumulated on the occlusal surface
Time Frame: On treatment day
|
First the presence of dental biofilm will be evaluated visually, according to the following index: 0: absence of visible biofilm; 1: visible but difficult to identify biofilm - best verified after drying; 2: Visible and easily identifiable biofilm - even without drying
|
On treatment day
|
|
Evaluation of the presence of visible biofilm on the buccal surfaces of the molars to be evaluated
Time Frame: On treatment day
|
0: absence of visible biofilm, 1: biofilm not visible, but removed from the gingival sulcus with the periodontal probe; 2: visible biofilm after drying; 3: abundant biofilm, visible even without drying.
|
On treatment day
|
|
Assessment of eruption degree
Time Frame: On treatment day
|
The degree of eruption will be assessed according to the following criteria (5): A: not erupted or less than 1/3 of the erupted occlusal surface or part of the crown of the visible incisor; B: totally erupted or at least 1/3, but less than the total occlusal surface erupted and / or less than the total crown length of the visible incisor.
|
On treatment day
|
|
Evaluation of lesion extension
Time Frame: On treatment day
|
The extent of lesion will be evaluated according to the following criterion (5): I: less than one third of the affected tooth, II: at least 1/3 of the affected tooth, but less than 2/3, III : at least 2/3 of the affected tooth.
|
On treatment day
|
|
Cost of procedures
Time Frame: On treatment day
|
To calculate the direct costs of the procedures, the time spent in each consultation (initials and reevaluations) will be taken into account.
The time will be timed and recorded in a specific clinical record.
For the calculation of direct costs, the prices of consumer and permanent materials (specifications and quantity) used in each procedure, electricity and the professional fee will be considered.
These values will be inferences of the market value obtained by average of different places that market the products in question, being updated during the time of the study.
In addition, the cost of equipment depreciation and electricity will be calculated.
|
On treatment day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MIHFORPUSP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.